3 European Stocks Estimated To Be Up To 45% Below Intrinsic Value

As European markets experience a boost from the prospect of lower U.S. borrowing costs, with the pan-European STOXX Europe 600 Index rising by 1.40%, investors are keenly observing opportunities within this favorable environment. Amidst this optimism, identifying stocks that are trading below their intrinsic value can present compelling investment prospects, especially when business activity in the eurozone is on an upward trajectory and manufacturing shows significant growth potential.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name	Current Price	Fair Value (Est)	Discount (Est)
Robit Oyj (HLSE:ROBIT)	€1.175	€2.28	48.4%
MilDef Group (OM:MILDEF)	SEK150.00	SEK291.08	48.5%
Hanza (OM:HANZA)	SEK112.00	SEK220.70	49.3%
E-Globe (BIT:EGB)	€0.665	€1.32	49.6%
Canatu Oyj (HLSE:CANATU)	€9.18	€17.87	48.6%
ATON Green Storage (BIT:ATON)	€2.09	€4.09	48.9%
Atea (OB:ATEA)	NOK145.20	NOK284.79	49%
Aquila Part Prod Com (BVB:AQ)	RON1.45	RON2.84	49%
Apotea (OM:APOTEA)	SEK106.44	SEK209.15	49.1%
ABO Energy GmbH KGaA (XTRA:AB9)	€36.90	€71.89	48.7%

Click here to see the full list of 210 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Underneath we present a selection of stocks filtered out by our screen.

Pluxee (ENXTPA:PLX)

Overview: Pluxee N.V. provides employee benefits and engagement solutions services across France, Latin America, Continental Europe, and internationally, with a market cap of €2.77 billion.

Operations: The company's revenue is derived from its operations in Continental Europe (€549 million), Latin America (€466 million), and the Rest of the World (€237 million).

Estimated Discount To Fair Value: 45%

Pluxee is trading at €19, significantly below its estimated fair value of €34.52, suggesting it may be undervalued based on cash flows. The company's earnings are forecasted to grow at 16.1% annually, outpacing the French market's 12.1%. Recent guidance reaffirms low double-digit organic revenue growth for 2025 and 2026, highlighting business resilience despite slower revenue growth compared to industry benchmarks. Return on Equity is projected to reach a very high level in three years.

• Insights from our recent growth report point to a promising forecast for Pluxee's business outlook.
• Delve into the full analysis health report here for a deeper understanding of Pluxee.

Vimian Group (OM:VIMIAN)

Overview: Vimian Group AB (publ) operates in the global animal health industry, with a market capitalization of SEK17.10 billion.

Operations: The company's revenue is derived from four main segments: Medtech (€142.10 million), Diagnostics (€22.50 million), Specialty Pharma (€178.20 million), and Veterinary Services (€61.60 million).

Estimated Discount To Fair Value: 24.9%

Vimian Group, trading at SEK32.76, is valued below its estimated fair value of SEK43.63, highlighting potential undervaluation based on cash flows. With earnings forecasted to grow significantly at 44.1% annually, it surpasses the Swedish market's growth rate of 16.8%. Recent earnings reports show positive momentum with net income rising from EUR 4.9 million to EUR 8.3 million year-over-year for Q2 2025, despite leadership changes that may impact future strategic direction.

• Our earnings growth report unveils the potential for significant increases in Vimian Group's future results.
• Click here to discover the nuances of Vimian Group with our detailed financial health report.

FACC (WBAG:FACC)

Overview: FACC AG, with a market cap of €364.03 million, develops, produces, and maintains aircraft components globally through its subsidiaries.

Operations: The company's revenue is derived from three main segments: Interiors (€406.84 million), Aerostructures (€346.83 million), and Engines & Nacelles (€177.13 million).

Estimated Discount To Fair Value: 40.4%

FACC, trading at €7.95, is priced below its estimated fair value of €13.33, suggesting undervaluation based on cash flows. Earnings are forecast to grow significantly at 59.8% annually, outpacing the Austrian market's 10.9%. Recent reports show Q2 sales increased to €253.71 million from €236.03 million year-over-year with net income rising to €9.29 million from €5.9 million, although profit margins have slightly declined and interest coverage remains a concern.

• Our comprehensive growth report raises the possibility that FACC is poised for substantial financial growth.
• Unlock comprehensive insights into our analysis of FACC stock in this financial health report.

Seize The Opportunity

• Embark on your investment journey to our 210 Undervalued European Stocks Based On Cash Flows selection here.
• Are these companies part of your investment strategy? Use Simply Wall St to consolidate your holdings into a portfolio and gain insights with our comprehensive analysis tools.
• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Seeking Other Investments?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com